Life Sciences

A Lancet Infectious Diseases analysis validates the safety and efficacy of RTS,S/AS01, the first malaria vaccine approved for widespread use. The finding matters: it could accelerate adoption in endemic regions and influence procurement decisions by health agencies and governments facing one of the world's deadliest infectious diseases.EN

Researchers have developed a nanotechnology platform that uses glutathione-scavenging particles to deliver cancer-fighting proteins directly to tumor cells, potentially improving treatment effectiveness while reducing side effects. The advance could accelerate development of next-generation cancer therapies and create commercial opportunities in precision oncology.EN

Researchers discovered that tumors create fatty environments that fuel their spread to distant organs—a finding that could reshape how the pharma industry designs cancer drugs. The discovery targets a specific molecular pathway, potentially opening doors to new treatments that block metastasis before it takes hold.EN

Researchers found that a protein called Neogenin suppresses cancer progression by interfering with a key growth-signaling pathway. The discovery could point toward new drug targets for treating metastatic tumors, offering potential clinical applications if validated in human trials.EN

Researchers have created a multiplexed screening method to quickly identify which anti-GPCR antibodies actually work as intended. The advance could accelerate drug development for companies targeting GPCRs—a class of proteins implicated in cancer, heart disease, and neurological conditions that represent roughly 30% of all FDA-approved drugs.EN

Scientists discovered that a single protein (NAMPT) acts as the master switch controlling how different tissues burn energy throughout the day. The finding could unlock new approaches to treating metabolic disorders like obesity and diabetes, and may reshape how pharmaceutical companies develop circadian-targeted therapeutics.EN

Scientists identified a protein called Bcl11b that acts as a master control for intestinal immune cells, keeping them flexible and combat-ready rather than locked into a single mode. The finding could help vaccine designers and biotech firms develop better defenses against food-borne pathogens and chronic gut diseases.EN

Researchers have pinpointed nephronectin, a specific protein, as a key driver linking obesity to severe COVID-19 outcomes. The discovery could unlock new drug targets and help identify high-risk patients earlier, potentially reshaping treatment strategies and drug development priorities for respiratory illness in obese populations.EN

Researchers have identified a mechanism by which Helicobacter pylori—a bacterium infecting roughly half the global population—may trigger Alzheimer's disease through immune signaling in the brain. The finding could reshape screening and treatment strategies for a bacterium typically considered a gastrointestinal concern, and may open new diagnostic or therapeutic avenues for neurodegenerative disease prevention.EN

Researchers have discovered that certain viral defense mechanisms can suppress harmful mutations in SAMD9 and SAMD9L genes, which cause rare blood disorders. The finding could open new treatment paths for patients with these conditions and may inform strategies for managing other genetically driven diseases.EN

Researchers found that rare genetic mutations linked to schizophrenia affect disease risk uniformly across diverse populations worldwide. The discovery matters because it could democratize mental health diagnostics and drug development—ensuring treatments and genetic screening tools work equally well for all patients, not just those of European descent.EN

Researchers used genetic analysis to distinguish genuine causal factors in Alzheimer's disease from mere correlations, potentially reshaping dementia prevention strategies and drug development priorities. The findings could help pharmaceutical companies and public health agencies focus resources on interventions with real biological impact rather than chasing associations that don't drive disease.EN

Researchers used single-cell genomics to decode how the epicardium—a thin heart layer—develops and contributes to cardiac disease. The findings could unlock new drug targets and regenerative therapies for heart conditions, potentially reshaping treatment strategies in cardiology and pharmaceutical development.EN

Blocking a single protein isn't enough to fight obesity—researchers found that inhibiting all versions of a protein called SHIP only works when immune cells called eosinophils are functioning normally. The finding could reshape how drugmakers design obesity treatments and screen candidates for efficacy before costly clinical trials.EN

Researchers have identified how a patient's genetic predisposition to breast cancer correlates with tumor characteristics and survival rates after diagnosis. The finding could help oncologists personalize treatment decisions and identify high-risk patients earlier, improving both clinical outcomes and healthcare resource allocation.EN

An international consortium analyzed brain scans from thousands of schizophrenia patients and controls, identifying consistent structural asymmetries that could improve diagnosis and treatment. The findings, published in PNAS, offer potential biomarkers for a condition that costs the U.S. healthcare system billions annually and affects treatment planning.EN

As people age, more bone marrow cells contribute to blood production, a finding that could reshape how we understand aging and blood disorders. The discovery, made using a new cellular tracking technique, suggests the body's blood-production system undergoes fundamental changes that might explain why older adults face higher risks of blood cancers and immune problems.EN

Scientists have discovered that natural selection is actively changing the human genome today, with a gene controlling fat metabolism showing measurable effects on reproductive success. The finding suggests human evolution isn't a historical curiosity—it's an ongoing biological process that could influence health outcomes and pharmaceutical development strategies.EN

Researchers have identified genetic risk factors that explain how T cell immune dysfunction and certain infections combine to cause narcolepsy, a chronic sleep disorder affecting roughly 1 in 2,000 people. The discovery could enable earlier detection and new drug targets—potentially reducing diagnosis delays that currently average 10 years.EN

Researchers discovered that exercise trains the microbiome to produce compounds that improve muscle metabolism, opening a new biological pathway for fitness benefits. The finding could reshape how companies develop probiotics and wellness products, and suggests the fitness industry's claims about gut health now have molecular backing.EN

Researchers have created a consensus blueprint for running fear-conditioning experiments on humans, addressing a major gap in how neuroscience labs conduct and compare their work. The standardized approach could accelerate development of therapies for PTSD, anxiety disorders, and phobias by making research results more reliable and reproducible across institutions.EN

Researchers developed a new method to distinguish harmful genetic variations from benign ones by analyzing which DNA regions have remained unchanged across mammalian evolution. The breakthrough could accelerate drug development and genetic testing by helping companies and clinicians identify mutations that actually cause disease rather than wading through thousands of genetic variants.EN

Researchers found a specific DNA structure within antibody genes that dramatically speeds up the immune system's ability to customize and improve infection-fighting proteins. The discovery could accelerate development of more effective vaccines and therapeutic antibodies, potentially opening new routes for biotech companies to engineer better treatments.EN

Forskare vid Stockholms universitet har utvecklat en gennätverksmodell för diapaus — dormansitillståndet som insekter använder för att överleva ogynnsamma miljöer — som förklarar både evolutionär historia och nuvarande populationsdynamik. Modellen kartlägger vilka gener som styr diapausbeslut och predikterar hur denna egenskap varierar mellan individer inom populationer. Denna koppling mellan macroevolutionär skala (artbildning över tid) och mikroevolutionär skala (variation inom arter) öppnar möjligheter att förutsäga hur populationer anpassar sig till klimatförändringar. För bioteknikföretag som utvecklar biologisk skadegöring eller jordbruksbiologiska lösningar blir genmodeller för överlevnadsstrategier kritiska — de möjliggör riskbedömning av introduceringen av nya organismer och förbättrar målriktningen av bekämpningsmedel. Forskningsdata är öppen tillgänglig via Zenodo, vilket underlättar validering och industriell tillämpning.

Könsskillnader i hjärnvolym påverkas av gemensamma genetiska mekanismer, inte nämnvärt olika mellan män och kvinnor i sen vuxenålder. Denna slutsats bygger på en genomsökning av 31 480 personer från UK Biobank, där forskare identifierade vilka genvarianter som påverkar 257 hjärnregioner separat för varje kön. Analysen avslöjade att heritabilitet och genetiska korrelationer mellan könen var likartade. Många genetiska loci återfanns i båda könen, men kvinnor hade fler identifierade gener kopplade till hjärnvolym än män — särskilt i limbiska regioner som insula, cingulat cortex, hippocampus och amygdala. Resultaten från Universitetet i Oslo och kanadensiska institutioner relevanta för utveckling av könsstratifierad psykiatrisk medicinering och diagnostik. För bolagsbyggare inom neuropsykiatrisk farmakologi underlättar dessa fynd målval för prekliniska program där könsgenetisk variation kan påverka effektivitet och säkerhet.